Jonathan I. Lieber - Feb 1, 2023 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Chief Financial Officer and Treasurer
Signature
/s/ Michael Greco, Attorney-in-Fact
Stock symbol
RLYB
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/1/2023, 05:33 PM
Previous filing
Jan 5, 2023
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +240K $0.00 240K Feb 1, 2023 Common Stock 240K $6.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of Common Stock on February 1, 2024 and as to the remaining 75% of the underlying shares of Common Stock in 36 equal monthly installments thereafter.

Remarks:

Chief Financial Officer and Treasurer